Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal Carcinomatosis

NCT04583488 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped PI left institution

Conditions

Peritoneal Carcinomatosis

Interventions

DRUG: Intraperitoneal docetaxel

Sponsor

Johns Hopkins University